Many of you ask us which of the stocks in Prime Stocks you should buy. While our response has always been that all the stocks in our buy list are a Buy, there are always some stocks that will seem better than others at certain points, depending on when you enter.
On this special occasion of Diwali, we therefore thought we will highlight 5 Prime stocks that you can enter today without much worry about rich price or valuation.
Here are 5 Prime Picks that you can enter on SAMVAT 2080. Before you dive in, please take time to understand the various categories under Prime Stocks (High growth, compounders, tactical plays, dividend earners and early movers) and decide which ones will fit your portfolio. Also, if you are a new subscriber, please take time to read our article on how to time your entry with Prime Stocks.
The 5 Prime Picks
1. HDFC AMC
For detailed analysis, read our report :
Prime Stock recommendation – A financial stock trying to make a comeback – PrimeInvestor
2. Cipla
For detailed analysis, read our report:
Prime Stock recommendation – A pharma stock available at a bargain – PrimeInvestor
3. Infosys
For detailed analysis, read our report:
Stock alert – Narratives and numbers – what to do with Infosys? – PrimeInvestor
4. Marico
For detailed analysis, read our report:
Prime Stock Recommendation – A consumer stock on a compounding journey – PrimeInvestor
5. V-Guard Industries
For detailed analysis, read our report here:
Research report of V-Guard Industries
Disclosures and Disclaimers
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (hereinafter referred to as the Regulations).
1. PrimeInvestor Financial Research Pvt Ltd is a SEBI-Registered Research Analyst having SEBI registration number INH200008653. PrimeInvestor Financial Research Pvt Ltd, the research entity, is engaged in providing research services and information on personal financial products. This Research Report (called Report) is prepared and distributed by PrimeInvestor Financial Research Pvt Ltd with brand name PrimeInvestor.
2. PrimeInvestor Financial Research Pvt Ltd, its partners, employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.
3. We, author/s and the name/s in this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. We or our relative or PrimeInvestor Financial Research Pvt Ltd do not have any financial interest in the subject company.
We or our relative or PrimeInvestor Financial Research Pvt Ltd do not have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. I/we or my/our relative or PrimeInvestor Financial Research Pvt Ltd do not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-month period.
4. The analysts in the Company publishing this report may hold these stocks as part of their investment portfolio. The list of these stocks held by analysts in the Company can be found here . The analysts in the Company have not traded in the subject stock thirty days preceding this research report and will not trade within five days of publication of the research report as required by regulations.
5. PrimeInvestor Financial Research Pvt Ltd has not received any compensation from the subject company in the past twelve months. PrimeInvestor Financial Research Pvt Ltd has not been engaged in market making activity for the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, PrimeInvestor Financial Research Pvt Ltd has not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report.
